KOREA WHO
-
-
Chairman of Whanin Pharm
Lee Gwang-sik
Focusing on Growth Through Global Pharma Partnerships, Expanding Interest in Health Supplements
-
Last Updated on Mar 6, 2025
-
Chairman of Whanin Pharm
Copy Url : https://www.koreawho.com/profile/LeeGwangsik- Life Summary
Lee Gwang-sik is the Chairman and CEO of Whanin Pharm.
He is focusing on increasing sales by distributing global pharmaceutical companies' drugs in the domestic market.
He was born on November 5, 1947, in Daejeon.
He graduated from Namseong High School in Iksan, North Jeolla Province, and earned a degree in pharmacy from Seoul National University. He later obtained a master's degree from the Graduate School of Public Health at Seoul National University.
He began his career at Chong Kun Dang.
In 1978, he acquired Whanin Pharm and expanded the business through collaborations with global pharmaceutical companies.
He is currently preparing to transfer management rights to his son, Lee Won-beom, who serves as co-CEO.
#WhaninPharm #LeeGwangSik #pharmaceuticals #globalbusiness #healthcare #startup #businessleadership #ChongKunDang #drugdistribution #managementsuccession
He is focusing on increasing sales by distributing global pharmaceutical companies' drugs in the domestic market.
He was born on November 5, 1947, in Daejeon.
He graduated from Namseong High School in Iksan, North Jeolla Province, and earned a degree in pharmacy from Seoul National University. He later obtained a master's degree from the Graduate School of Public Health at Seoul National University.
He began his career at Chong Kun Dang.
In 1978, he acquired Whanin Pharm and expanded the business through collaborations with global pharmaceutical companies.
He is currently preparing to transfer management rights to his son, Lee Won-beom, who serves as co-CEO.
#WhaninPharm #LeeGwangSik #pharmaceuticals #globalbusiness #healthcare #startup #businessleadership #ChongKunDang #drugdistribution #managementsuccession
- Life Summary
- Career Highlights & Challenges
- · Whanin Pharm's Governance Structure
- · Increased Revenue from Global Pharmaceutical Distribution, but Higher Costs Reduce Operating Profit
- · Subsidiary AsYou Launches Three Eye Health Supplements
- · Launch of Brain Metabolism Enhancer Niseon Tab 10mg
- · Acquisition of Health Supplement Company Bifido Completed
- · Paid KRW 4.58 Billion in 2023 Year-End Dividends
- · Epilepsy Treatment Peranel Tablets Launched
- · Hyangnam Plant Begins Operations
- · Distribution Agreement with GlaxoSmithKline for Six CNS Drugs
- · Son Lee Won-bum Appointed CEO, Father-Son Leadership Begins
- · History of Whanin Pharm
- Vision and Goals
- Market and Social Evaluation
- Notable Incidents & Legal Affairs
- Professional Timeline
- Educational Background
- Family & Personal Connections
- Awards & Recognitions
- Additional Information
- Notable Quotations
- Infographic & Photos